×
About 163 results

ALLMedicine™ Lung Cancer Biomarkers Center

Research & Reviews  69 results

Age-stratified and gender-specific reference intervals of six tumor markers panel of lu...
https://doi.org/10.1002/jcla.23816
Journal of Clinical Laboratory Analysis; Li Y, Li M et. al.

May 13th, 2021 - Serum biomarkers have been widely adopted in clinical practice for assisting lung cancer diagnoses, therapeutic monitoring, and prognostication. The function of a well-performing tumor biomarker depends on a reliable reference interval (RI) with c...

"Randomized trial of physical activity on quality of life and lung cancer biomarkers in...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015735
BMC Cancer; Bade BC, Gan G et. al.

Apr 2nd, 2021 - Lung cancer survivors need more options to improve quality of life (QoL). It is unclear to what extent patients with advanced stage disease are willing to participate in home-based physical activity (PA) and if these interventions improve QoL. The...

Next generation sequencing for liquid biopsy based testing in non-small cell lung cance...
https://doi.org/10.1016/j.critrevonc.2021.103311
Critical Reviews in Oncology/hematology; Pisapia P, Costa JL et. al.

Mar 30th, 2021 - Lung cancer is the leading cause of cancer death worldwide, with non-small cell lung cancer (NSCLC) representing its most commonly diagnosed sub-type. Despite the significant improvements in lung cancer biomarkers knowledge, accompanied by substan...

Volatile organic compounds in human matrices as lung cancer biomarkers: a systematic re...
https://doi.org/10.1016/j.critrevonc.2020.103037
Critical Reviews in Oncology/hematology; Janssens E, van Meerbeeck JP et. al.

Aug 10th, 2020 - Volatile organic compounds (VOCs) have shown potential as non-invasive breath biomarkers for lung cancer, but their unclear biological origin currently limits clinical applications. This systematic review explores headspace analysis of VOCs in pat...

Plasma RNA sequencing of extracellular RNAs reveals potential biomarkers for non-small ...
https://doi.org/10.1016/j.clinbiochem.2020.06.004
Clinical Biochemistry; Wang L, Wang J et. al.

Jun 11th, 2020 - Lung cancer is one of the most common malignancies, and it has extremely high incidence and mortality rates. Although there have been many studies focused on lung cancer biomarkers, few have reported the extracellular RNA profiles of lung cancer. ...

see more →

Guidelines  9 results

The prognostic significance of circulating tumor cells in head and neck and non‐small‐cell lung cancer
https://onlinelibrary.wiley.com/doi/full/10.1002/cam4.1832
Kulasinghe,A.,et al

Nov 21st, 2018 - Tumor biopsy is the gold standard for the assessment of clinical biomarkers for treatment. However, tumors change dynamically in response to therapy, and there remains a need for a more representative biomarker that can be assayed over the course ...

Molecular Testing for the Selection of Patients With Lung Cancer for Treatment With Targeted...
http://ascopubs.org/doi/full/10.1200/JCO.2017.76.7293
Gregory P. Kalemkerian

Mar 19th, 2018 - In response to advances in the field, the College of American Pathologists (CAP), the International Association for the Study of Lung Cancer (IASLC), and the Association forMolecular Pathology (AMP) recently updated their recommendations for molec.

Lung Cancer Biomarkers
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5137804/
Hematology/oncology Clinics of North America; Villalobos P

Jan 31st, 2018 - The molecular characterization of lung cancer has considerably changed the classification and treatment of these tumors, becoming an essential component of pathologic diagnosis and oncologic therapy decisions. Through the recognition of novel biom...

New Strategies and Challenges in Lung Proteomics and Metabolomics
http://www.thoracic.org/statements/resources/research/strategies-challenges%20-lung-proteomics-and-metabolomics.pdf
Russell P. Bowler

Nov 30th, 2017 - This document presents the proceedings from the workshop entitled, "New Strategies and Challenges in Lung Proteomics and Metabolomics" held February 4th-5th, 2016, in Denver, Colorado. It was sponsored by the National Heart Lung Blood Institute, t.

IASLC Atlas of PD-L1 Testing in Lung Cancer
https://www.iaslc.org/publications/iaslc-atlas-pd-l1-testing-lung-cancer
IASLC

Sep 30th, 2017 - The IASLC Atlas of PD-L1 Immunohistochemistry Testing in Lung Cancer is a new resource for understanding programmed cell death ligand-1 (PD-L1) immunohistochemistry (IHC) assays.

see more →

Drugs  1 results see all →

Clinicaltrials.gov  81 results

Age-stratified and gender-specific reference intervals of six tumor markers panel of lu...
https://doi.org/10.1002/jcla.23816
Journal of Clinical Laboratory Analysis; Li Y, Li M et. al.

May 13th, 2021 - Serum biomarkers have been widely adopted in clinical practice for assisting lung cancer diagnoses, therapeutic monitoring, and prognostication. The function of a well-performing tumor biomarker depends on a reliable reference interval (RI) with c...

"Randomized trial of physical activity on quality of life and lung cancer biomarkers in...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015735
BMC Cancer; Bade BC, Gan G et. al.

Apr 2nd, 2021 - Lung cancer survivors need more options to improve quality of life (QoL). It is unclear to what extent patients with advanced stage disease are willing to participate in home-based physical activity (PA) and if these interventions improve QoL. The...

Next generation sequencing for liquid biopsy based testing in non-small cell lung cance...
https://doi.org/10.1016/j.critrevonc.2021.103311
Critical Reviews in Oncology/hematology; Pisapia P, Costa JL et. al.

Mar 30th, 2021 - Lung cancer is the leading cause of cancer death worldwide, with non-small cell lung cancer (NSCLC) representing its most commonly diagnosed sub-type. Despite the significant improvements in lung cancer biomarkers knowledge, accompanied by substan...

Volatile organic compounds in human matrices as lung cancer biomarkers: a systematic re...
https://doi.org/10.1016/j.critrevonc.2020.103037
Critical Reviews in Oncology/hematology; Janssens E, van Meerbeeck JP et. al.

Aug 10th, 2020 - Volatile organic compounds (VOCs) have shown potential as non-invasive breath biomarkers for lung cancer, but their unclear biological origin currently limits clinical applications. This systematic review explores headspace analysis of VOCs in pat...

Plasma RNA sequencing of extracellular RNAs reveals potential biomarkers for non-small ...
https://doi.org/10.1016/j.clinbiochem.2020.06.004
Clinical Biochemistry; Wang L, Wang J et. al.

Jun 11th, 2020 - Lung cancer is one of the most common malignancies, and it has extremely high incidence and mortality rates. Although there have been many studies focused on lung cancer biomarkers, few have reported the extracellular RNA profiles of lung cancer. ...

see more →

News  3 results

The prognostic significance of circulating tumor cells in head and neck and non‐small‐cell lung cancer
https://onlinelibrary.wiley.com/doi/full/10.1002/cam4.1832
Kulasinghe,A.,et al

Nov 21st, 2018 - Tumor biopsy is the gold standard for the assessment of clinical biomarkers for treatment. However, tumors change dynamically in response to therapy, and there remains a need for a more representative biomarker that can be assayed over the course ...

Lung Cancer Biomarkers
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5137804/
Hematology/oncology Clinics of North America; Villalobos P

Jan 31st, 2018 - The molecular characterization of lung cancer has considerably changed the classification and treatment of these tumors, becoming an essential component of pathologic diagnosis and oncologic therapy decisions. Through the recognition of novel biom...

Deciphering lung cancer biomarkers shrouded in tobacco smoke
https://www.mdedge.com/familymedicine/article/105905/lung-cancer/deciphering-lung-cancer-biomarkers-shrouded-tobacco-smoke/page/0/1
Family Practice News;

Jan 20th, 2016 - In addition, the exposure biomarkers are not entirely predictive and thus, will need to be combined with multiple DNA adducts and repair if susceptible smokers are to be identified and targeted for state-of-the art cessation approaches and surveil.

see more →